Landel Ina, Quambusch Lena, Depta Laura, Rauh Daniel
Faculty of Chemistry and Chemical Biology, TU Dortmund University and Drug Discovery Hub Dortmund (DDHD), Zentrum für Wirkstoffforschung (ZIW), Otto-Hahn-Strasse 4a, 44227 Dortmund, Germany.
ACS Med Chem Lett. 2020 Mar 12;11(3):225-227. doi: 10.1021/acsmedchemlett.9b00548.
The protein kinase B (Akt) exemplifies an important switch of cell death and survival within the PI3K/Akt signaling pathway, which renders Akt a valuable target in diseases such as cancer. Herein, we give a short overview of clinical applications involving Akt, outline promising and innovative approaches to investigate the role of this kinase in diseases, and highlight the current challenges that require thorough investigation to set the groundwork for successful therapeutic strategies.
蛋白激酶B（Akt）是PI3K/Akt信号通路中细胞死亡和存活的重要开关，这使得Akt成为癌症等疾病中有价值的靶点。在此，我们简要概述涉及Akt的临床应用，概述研究该激酶在疾病中作用的有前景和创新性方法，并强调当前需要深入研究以奠定成功治疗策略基础的挑战。
